WAVEMAN · COMPANY

CV · Capsovision, Inc

LIVE

TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475

← ALL COMPANIES

CV

Name: CapsoVision, Inc (CV) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

CapsoVision, Inc

MEDICAL DEVICES · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · CIK 0001378325

SEC FILINGS☆ WATCH

INSIDER NET · 180D

$999.3K

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

+15.3%

XBRL, annual

NET MARGIN

-186.8%

CONVERSIONS · 180D

codes C/M, not in net · $137.1K priced

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net +$999.3K over 180 days

+$999.3K over 90 days · +$1.0M of it by a 10%+ holder

more than 92% of Medical Devices

CONGRESS

no member of Congress has reported trading it

FUNDS

38 funds added or opened last quarter

below 66% of Medical Devices

REVENUE

+15.3% year over year

more than 66% of Medical Devices

MARGIN

-186.8% net margin

below 87% of Medical Devices

BUYBACKS

no share repurchases reported

SHORT

3.8% of shares outstanding short · 21.1 days to cover · settled 2026-07-31

more than 53% of Medical Devices

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

38 funds added or opened positions in the latest 13F quarter, of 52 holders.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN +63.6%

+63.6%12M

INSIDER BUYINSIDER SELL

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

Insiders are net buyers of their own stock.

The record shows a net $999.3K bought by insiders over 180 days, 38 funds added last quarter. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

TMO PEN ROK BLFS MTD SIBN WRBY ISRG TXG DXCM EW TMDX

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, CapsoVision, Inc insiders bought a net $999.3K of stock across 5 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER

FILED

VALUE

HARARI ELIYAHOU ET AL

—

BUY

2026-07-17

61,068.0

$411.0K

HARARI ELIYAHOU ET AL

—

BUY

2026-07-08

81,300.0

$495.1K

HARARI ELIYAHOU ET AL

—

BUY

2026-06-26

13,850.0

$101.8K

Imperial Joanne Carol

Director

SELL

2026-06-08

1,200.0

$8.6K

Tsai Chen Lung

Director

BUY

2025-07-03

20.0

$83

5 TRANSACTIONS ON RECORD · THIN RECORD, READ IT AS SUCH

Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

BlackRock, Inc.

1,896,088.0 sh

$14.4M

VANGUARD CAPITAL MANAGEMENT LLC

1,058,468.0 sh

$8.0M

GEODE CAPITAL MANAGEMENT, LLC

578,482.0 sh

$4.4M

STATE STREET CORP

410,241.0 sh

$3.1M

VANGUARD PORTFOLIO MANAGEMENT LLC

240,425.0 sh

$1.8M

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

iShares Micro-Cap ETF

$511.5K POSITION · AS OF 2026-03-31

0.0%

1290 VT Micro Cap Portfolio

$35.3K POSITION · AS OF 2026-03-31

0.0%

PD Small-Cap Growth Index Portfolio

$11.7K POSITION · AS OF 2026-03-31

0.0%

Fidelity Small Cap Growth Index Fund

$105.2K POSITION · AS OF 2026-03-31

0.0%

iShares Russell 2000 Growth ETF

$1.1M POSITION · AS OF 2026-03-31

0.0%

MetLife Russell 2000 Index Portfolio

$70.7K POSITION · AS OF 2026-03-31

0.0%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12
REVENUE	$13.6M	$11.8M
GROSS PROFIT	$7.2M	$6.4M
OPERATING INCOME	$-25.5M	$-19.9M
NET INCOME	$-25.3M	$-19.9M
EPS (DILUTED)	-1.03	-9.85
OPERATING CASH FLOW	$-22.9M	$-20.1M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE